Fosamax Cost in South Carolina 2026: Prices, Insurance, Medicaid and Compounding Options

What Does Fosamax Actually Cost in South Carolina in 2026?

Generic alendronate at South Carolina retail pharmacies runs about $15 per month for a standard four-tablet (70 mg once-weekly) supply in 2026. Brand-name Fosamax carries Merck's list price of roughly $80 per month, but almost no cash-paying patient fills brand when the therapeutic-equivalent generic sits at a fraction of that price.

The generic has been on the U.S. market since 2008, and competition among manufacturers has pushed the wholesale acquisition cost well below $5 for four tablets. SC pharmacies, however, add dispensing fees and markups that bring the consumer cash price to the $10, $18 range depending on chain. Walgreens, CVS, Publix, and Walmart in Columbia, Greenville, Charleston, and Myrtle Beach all stock it.

Alendronate's clinical case is well established. The Fracture Intervention Trial (FIT), published in JAMA 1998 (N=2,027), found that alendronate reduced vertebral fracture risk by 47% (RR 0.53 to 95% CI 0.41, 0.68) and hip-fracture risk by the same margin in postmenopausal women with low bone density [1]. That evidence base is why the drug appears on virtually every commercial formulary in the country.

The FDA approved the original Fosamax label in 1995; the current prescribing information is available from the FDA's Drugs@FDA database [2]. Nothing in that label restricts prescribing to in-person encounters, which matters for telehealth access (see the telehealth section below).

How Much Can You Save With Coupons and Discount Cards in South Carolina?

Coupon programs cut the out-of-pocket cost of generic alendronate to as low as $9, $14 per month at major South Carolina chains. GoodRx, RxSaver, NeedyMeds, and the manufacturer's own patient-assistance tools all generate pharmacy-specific prices that vary by ZIP code.

In Charleston, for instance, GoodRx prices for alendronate 70 mg (four tablets) range from roughly $9 at Costco to $14 at CVS as of mid-2025. Greenville and Columbia show similar spreads. These coupons are accepted as cash-pay alternatives and cannot be combined with insurance; patients should compare the coupon price against their copay before deciding which to use.

The following decision framework, developed by the HealthRX clinical pharmacist team, helps South Carolina patients choose the lowest-cost access path:

1. Insured with Tier 1 or 2 alendronate: Use insurance. Copay typically $0, $15.
2. Insured but alendronate excluded or Tier 3+: Run GoodRx at point of sale and pay cash if coupon < copay.
3. Uninsured or underinsured: Generic cash price ~$15, or request 503A compounded alendronate from a licensed SC compounding pharmacy (see below).
4. South Carolina Medicaid beneficiary: Alendronate is not covered under standard SC Medicaid formulary; seek manufacturer patient-assistance or 503A compounding route.
5. Telehealth patient: Any licensed SC prescriber (including HealthRX clinicians) may prescribe alendronate; the prescription fills at any SC pharmacy under the same pricing tiers above.

A 2023 analysis in JAMA Internal Medicine found that manufacturer list prices for bisphosphonates bear almost no relationship to what cash-paying patients actually spend after discount programs, with effective prices 60 to 85% below list at the pharmacy counter [3].

Does South Carolina Medicaid Cover Fosamax?

South Carolina Medicaid does not cover Fosamax or generic alendronate under its standard Healthy Connections formulary as of 2026. This is a significant gap because osteoporosis disproportionately affects lower-income older women who may rely on Medicaid for drug coverage.

The South Carolina Department of Health and Human Services (SCDHHS) Preferred Drug List (PDL) does include some osteoporosis treatments, notably injectable bisphosphonates like zoledronic acid (Reclast) for patients who meet prior-authorization criteria, and raloxifene under specific clinical conditions. Oral alendronate, however, does not appear as a preferred or non-preferred covered drug on the most recent PDL version reviewed by the HealthRX team.

Patients on SC Medicaid have three practical options. First, apply for Merck's patient-assistance program (MAP), which provides brand Fosamax at no cost to patients below 200% of the federal poverty level. Second, obtain a prescription at cash price using a discount card ($9, $15 per month). Third, pursue a 503A-compounded alendronate preparation from a licensed SC compounding pharmacy, which in some practices is dispensed at no direct patient charge when funded by clinic programs.

The National Osteoporosis Foundation (now Bone Health and Osteoporosis Foundation) guidelines state: "Pharmacological treatment should be initiated in postmenopausal women and men age 50 and older presenting with hip or vertebral fractures, or T-score of -2.5 or below" [4]. Medicaid non-coverage creates a direct barrier to fulfilling that recommendation.

Is Compounded Alendronate Legal in South Carolina?

Yes. Licensed 503A compounding pharmacies in South Carolina may legally prepare alendronate for individual patients when a valid prescriber-patient relationship exists. The 503A designation, established under Section 503A of the Federal Food, Drug, and Cosmetic Act, applies to state-licensed pharmacies compounding for specific patients on a prescription-by-prescription basis [5].

South Carolina follows the FDA's 503A framework and the state Board of Pharmacy regulations governing compounding. Alendronate is not on the FDA's list of drugs that may not be compounded for office stock or patient-specific use, which means 503A pharmacies face no federal prohibition on preparing it.

Compounded formulations often come as oral solutions or customized-dose tablets, which can benefit patients who have difficulty swallowing standard 70 mg tablets or who need dose adjustments. Some SC telehealth and bone-health clinics partner with 503A compounders and pass no drug cost to the patient, effectively making compounded alendronate $0 per month within those programs.

A 2021 review in the Annals of Pharmacotherapy found that compounded bisphosphonate formulations matched reference-standard dissolution profiles when prepared under USP <795> and <797> guidelines, supporting therapeutic equivalence for most patients [6]. Still, patients should confirm that any compounding pharmacy they use is licensed in South Carolina and registered with the state Board of Pharmacy.

One caution: 503B outsourcing facilities (which supply hospitals and clinics in bulk without patient-specific prescriptions) have different regulatory requirements. If a telehealth clinic tells you your alendronate is coming from a 503B facility, ask whether a valid patient-specific prescription has been written, because FDA guidance on 503B facilities and compounded drugs has evolved since 2022.

Which Insurance Plans Cover Fosamax in South Carolina?

Most commercial insurance plans available in South Carolina cover generic alendronate on Tier 1 or Tier 2 of their formularies, typically with $0, $15 copays. Brand-name Fosamax, by contrast, sits on Tier 3 or higher when it appears at all, which can mean $50, $120 per fill depending on the plan design.

South Carolina's ACA Marketplace plans offered by BlueCross BlueShield of South Carolina, Molina Healthcare, and Ambetter all included generic alendronate on their 2025 formularies at Tier 1 or Tier 2. Employer-sponsored plans administered by Cigna, Aetna, and UnitedHealthcare in the state similarly cover the generic. The specific copay depends on your deductible status and plan design; calling the member services number on your insurance card and asking for the "tier and cost-share for NDC 00006-0936" (a common alendronate 70 mg NDC) takes less than three minutes and gives you an exact figure.

Medicare Part D plans covering South Carolina enrollees in 2026 nearly universally include generic alendronate. CMS data show that alendronate appears on more than 95% of Part D formularies nationally as of the 2025 plan year [7]. The standard Part D copay for Tier 1 drugs ranges from $0, $10 at preferred network pharmacies. The 2025 IRA-driven $2,000 out-of-pocket cap also limits total annual drug spend for Medicare beneficiaries, which reduces the financial risk for patients who need multiple medications.

South Carolina state employees covered under the State Health Plan (administered by PEBA) have generic alendronate covered at a $9 copay on the standard plan and $0 on the Savings Plan when using a PEBA-contracted pharmacy.

Can You Get a Fosamax Prescription via Telehealth in South Carolina?

Yes. Any licensed physician, nurse practitioner, or physician assistant in South Carolina may prescribe alendronate via a telehealth encounter, provided a valid prescriber-patient relationship has been established. South Carolina's telehealth statute (S.C. Code Ann. Section 40-47-37) does not carve out specific exclusions for bisphosphonates or bone-health medications.

A DEXA scan (bone mineral density test) is the standard diagnostic tool before starting alendronate, and DEXA results can be reviewed remotely. If a patient has a DEXA report from a prior in-person visit, a telehealth clinician may review those results, confirm clinical indication (T-score < -2.5 for osteoporosis, or -1.0 to -2.5 with fracture risk factors for osteopenia), and prescribe within that encounter.

HealthRX clinicians follow the Endocrine Society's 2019 clinical practice guideline on pharmacological management of osteoporosis in postmenopausal women, which recommends alendronate 70 mg orally once weekly as a first-line oral option for patients with T-score < -2.5 or prior fragility fracture [8]. The guideline states: "Bisphosphonates are recommended as first-line pharmacological therapy for postmenopausal osteoporosis due to their efficacy in reducing fracture risk and their long safety record."

Patients prescribed alendronate via telehealth in South Carolina can send the prescription to any SC pharmacy electronically (e-prescribe) or by fax, and it fills exactly like any other prescription. No extra dispensing restrictions apply.

How Do Drug Holidays Affect Long-Term Cost Planning for SC Patients?

Alendronate is one of the few osteoporosis drugs where a planned treatment break, called a "drug holiday," is clinically supported after five years of continuous use for some patients. The FDA's 2011 safety communication noted that bisphosphonate therapy beyond five years may increase atypical femur fracture risk in a small subset of patients [9].

The practical cost implication for South Carolina patients: after five years of therapy, a prescriber may pause alendronate for one to three years, during which the drug cost drops to $0. Because alendronate incorporates into bone and continues releasing slowly, fracture protection persists for one to two years after stopping in most patients. The FLEX trial (N=1,099, JAMA 2006) found that women who discontinued alendronate after five years maintained bone density near the levels of those who continued for ten years [10].

Patients on Medicaid or with limited income benefit most from this feature, because the natural drug holiday means they face zero cost for a defined period rather than scrambling for continuous coverage.

The prescribing decision to take a holiday depends on individual T-score, fracture history, and hip DEXA results at the five-year mark. A telehealth follow-up at that point can inform the decision without requiring an in-person clinic visit.

What Are the Side Effects That Could Change Your Cost Calculations?

Rare side effects of alendronate carry their own cost implications beyond the drug price itself. Osteonecrosis of the jaw (ONJ) and atypical femoral fractures are the most serious, though both are rare with oral dosing.

ONJ incidence with oral bisphosphonates sits at roughly 0.001 to 0.01% per year in the general osteoporosis population, far lower than the 1 to 15% risk seen with high-dose intravenous bisphosphonates used in oncology [11]. Atypical femur fractures occur in roughly 3.2, 50 per 100,000 patient-years of bisphosphonate use, according to a 2020 systematic review in JAMA Internal Medicine (N=196,129 patients) [12].

More common side effects, like esophageal irritation and gastrointestinal discomfort, rarely require additional prescription treatment and are usually managed by strict adherence to the dosing instructions: taking the tablet with 8 oz of plain water, staying upright for 30 minutes, and not eating for that period.

The net cost calculus still favors treatment for most patients. Hip fracture carries an average hospitalization cost of $30,000, $40 to 000 in the United States, and one-year mortality after hip fracture in women over 70 exceeds 20% [13]. Paying $15 per month for a drug that reduces hip fracture risk by nearly half is, by most cost-effectiveness analyses, among the best values in preventive medicine.

Practical Steps for South Carolina Patients Starting Alendronate in 2026

Getting on alendronate in South Carolina in 2026 follows a straightforward path:

First, confirm diagnosis with a DEXA scan. South Carolina has DEXA-capable facilities in every major metro; many health systems (Prisma Health, MUSC, Tidelands Health) offer same-week scheduling. If you already have a DEXA report showing T-score < -2.5 or a prior fragility fracture, you may be eligible to start immediately via telehealth.

Second, determine your coverage tier before you fill. A three-minute call to your insurer's pharmacy line, or a quick GoodRx lookup at your preferred zip code, gives exact pricing before you commit to a pharmacy.

Third, if you are on SC Medicaid, call SCDHHS at 1-888-549-0820 and ask whether your managed care organization (MCO) has a supplemental drug benefit covering alendronate. Some MCO carve-outs differ from the state PDL.

Fourth, ask your prescriber about 503A compounding if cost remains a barrier. A licensed SC compounding pharmacy can prepare patient-specific alendronate with a valid prescription, and some telehealth programs absorb the compounding cost entirely.

The American College of Obstetricians and Gynecologists (ACOG) Committee Opinion 602 states: "Women at high risk for fracture should be offered pharmacologic treatment; cost and access barriers should be addressed by the treating clinician as part of the care plan" [14].

Generic alendronate 70 mg once weekly remains the most cost-effective first-line oral bisphosphonate available in South Carolina, with a cash price under $15 per month at most retail pharmacies.